Resultats de la cerca - Francesco Franchi

Refinar resultats
  1. 1
    Diabetes and antiplatelet therapy: from bench to bedside

    Diabetes and antiplatelet therapy: from bench to bedside per José Ríos, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice

    Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice per Ana Muñiz‐Lozano, Fabiana Rollini, Francesco Franchi, Dominick J. Angiolillo

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations

    Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations per Mattía Galli, Francesco Franchi, Fabiana Rollini, Larisa H. Cavallari, Davide Capodanno, Filippo Crea, Dominick J. Angiolillo

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Role of genetic testing in patients undergoing percutaneous coronary intervention

    Role of genetic testing in patients undergoing percutaneous coronary intervention per Jae Youn Moon, Francesco Franchi, Fabiana Rollini, José Ríos, Megha Kureti, Larisa H. Cavallari, Dominick J. Angiolillo

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

    Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI per Dominick J. Angiolillo, Francesco Franchi, Ron Waksman, Joseph Sweeny, Ganesh Raveendran, Renli Teng, Yonggang Zhao, Glenn Carlson, Naeem Khan, Roxana Mehran

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study

    Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study per Francesco Franchi, Dmitry Yaranov, Fabiana Rollini, Andrea Rivas, Jose Rivas Rios, Latonya Been, Yuma Tani, Masaaki Tokuda, Tetsuo Iida, Noriko Hayashi, Dominick J. Angiolillo, Arshag D. Mooradian

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

    Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of... per Luis Ortega‐Paz, Mattía Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C. Michael Gibson, Renato D. Lópes, Felicita Andreotti, Dominick J. Angiolillo

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease per Francesco Franchi, Fabiana Rollini, Niti R. Aggarwal, Jenny Hu, Megha Kureti, Ashwin Durairaj, Valeria E. Duarte, Jung Rae Cho, Latonya Been, Martin M. Zenni, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y <sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

    Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y <sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndrom... per Francesco Franchi, Stefan James, Tatevik Ghukasyan Lakic, Andrzej Budaj, Jan H. Cornel, Hugo A. Katus, Matyàs Keltai, Frederic Kontny, Basil S. Lewis, Robert F. Storey, Anders Himmelmänn, Lars Wallentin, Dominick J. Angiolillo

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

    Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention per Larisa H. Cavallari, Francesco Franchi, Fabiana Rollini, Latonya Been, Andrea Rivas, Malhar Agarwal, D. Max Smith, Kimberly J. Newsom, Yan Gong, Amanda R. Elsey, Petr Starostik, Julie A. Johnson, Dominick J. Angiolillo

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

    Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease per Dominick J. Angiolillo, Joseph A. Jakubowski, José Luis Ferreiro, Antonio Tello‐Montoliu, Fabiana Rollini, Francesco Franchi, Masafumi Ueno, Andrew Darlington, Bhaloo Desai, Brian A. Moser, Atsuhiro Sugidachi, Luis A. Guzmán, Theodore A. Bass

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention per Francesco Franchi, Fabiana Rollini, Jung Rae Cho, M. Tariq Bhatti, Christopher DeGroat, Elisabetta Ferrante, Elizabeth Cullen Dunn, Amit Nanavati, Edward Carraway, Siva Suryadevara, Martin M. Zenni, Luis A. Guzmán, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

    Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention per Fabiana Rollini, Francesco Franchi, Jenny Hu, Megha Kureti, Niti R. Aggarwal, Ashwin Durairaj, Yongwhi Park, Michael Seawell, Pedro Cox‐Alomar, Martin M. Zenni, Luis A. Guzmán, Siva Suryadevara, Patrick Antoun, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

    Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial per Robert F. Storey, Dominick J. Angiolillo, Marc P. Bonaca, Mark R. Thomas, Heather M. Judge, Fabiana Rollini, Francesco Franchi, Arif Ahsan, Deepak L. Bhatt, Julia Kuder, Philippe Gabríel Steg, Marc Cohen, Rangasamy Muthusamy, Eugene Braunwald, Marc S. Sabatine

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

    A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized... per Fabiana Rollini, Francesco Franchi, Jung Rae Cho, Christopher DeGroat, M. Tariq Bhatti, Ana Muñiz‐Lozano, Kamaldeep Singh, Elisabetta Ferrante, Ryan E. Wilson, Elizabeth Cullen Dunn, Martin M. Zenni, Luis A. Guzmán, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor

    Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor per Francesco Franchi, Gabriel Faz, Fabiana Rollini, Yongwhi Park, Jung Rae Cho, Estela Thano, Jenny Hu, Megha Kureti, Niti R. Aggarwal, Ashwin Durairaj, Latonya Been, Martin M. Zenni, Luis A. Guzmán, Siva Suryadevara, Patrick Antoun, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention per Francesco Franchi, Fabiana Rollini, Andrea Rivas, Mustafa Wali, Maryuri Briceno, Malhar Agarwal, Zubair Shaikh, Ahmed Nawaz, Gabriel Silva, Latonya Been, Ramez Smairat, Marc Kaufman, Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease

    Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease per Francesco Franchi, Fabiana Rollini, Jose Rivas Rios, Andrea Rivas, Malhar Agarwal, Megha Kureti, Deepa Nagaraju, Mustafa Wali, Zubair Shaikh, Maryuri Briceno, Ahmed Nawaz, Jae Youn Moon, Latonya Been, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Theodore A. Bass, Dominick J. Angiolillo

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials

    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials per Mattía Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi‐Zoccai, Giovanni Maria Vescovo, Larisa H. Cavallari, Behnood Bikdeli, Jurriën M. ten Berg, Roxana Mehran, C. Michael Gibson, Filippo Crea, Naveen L. Pereira, Dirk Sibbing, Dominick J. Angiolillo

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Institutional Profile: University of Florida Health Personalized Medicine Program

    Institutional Profile: University of Florida Health Personalized Medicine Program per Larisa H. Cavallari, Kristin Weitzel, Amanda R. Elsey, Xinyue Liu, Scott A. Mosley, D. Max Smith, Benjamin Staley, Almut G. Winterstein, Carol A. Mathews, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo, Petr Starostik, Michael Clare‐Salzler, David R. Nelson, Julie A. Johnson

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: